Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/16/2011 | EP2295454A1 SLO2, a novel potassium channel protein from human brain |
03/16/2011 | EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
03/16/2011 | EP2295080A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
03/16/2011 | EP2295074A1 Anti-neovasculature preparations for treating cancer |
03/16/2011 | EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors |
03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
03/16/2011 | EP2294915A2 Nucleic acid constructs and methods for producing altered seed oil compositions |
03/16/2011 | EP2294201A1 Diacylglycerol acyltransferases from flax |
03/16/2011 | EP2294187A2 Differentiation of multi-lineage progenitor cells to pancreatic cells |
03/16/2011 | EP2294186A2 Inducing cell death by inhibiting adaptive heat shock response |
03/16/2011 | EP2294185A2 Multipotent adult stem cell population |
03/16/2011 | EP2294184A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
03/16/2011 | EP2294183A2 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage |
03/16/2011 | EP2294182A1 Multipotent stem cell cultures |
03/16/2011 | EP2294181A2 Modulation of smrt expression |
03/16/2011 | EP2294089A2 Anti-fn14 antibodies and uses thereof |
03/16/2011 | EP2173890B1 Biological active proteins having increased in vivo and/or vitro stability |
03/16/2011 | EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
03/16/2011 | EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
03/16/2011 | EP1694828B1 Serum-free vero cell banking process |
03/16/2011 | EP1572895B1 Methods for producing hyaluronan in a recombinant host cell |
03/16/2011 | EP1564285B1 Method of obtaining a recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media |
03/16/2011 | EP1551876B1 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof |
03/16/2011 | EP1404848B1 Gene expression in plastids based on replicating vectors |
03/16/2011 | EP1351565B1 Chemical inhibitors of mismatch repair |
03/16/2011 | EP1135532B1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
03/16/2011 | CN201762336U Reagent case convenient for in vitro construction of mammary gland acinar models |
03/16/2011 | CN201762308U Kit convenient for mammary epithelial cell isolation and identification |
03/16/2011 | CN1953767B Regulatory T cells suppress autoimmunity |
03/16/2011 | CN1951177B A seedling environment training method for ginger tissue cultured test-tube seedling |
03/16/2011 | CN101985634A GFP membrane type expression vector and method for sorting vector-transfected positive cells |
03/16/2011 | CN101985622A Promoter BgIosP572 and preparation method and application thereof |
03/16/2011 | CN101985621A Molecular mark SIsvo188 closely linked with herbicide-resistant gene in foxtail millet |
03/16/2011 | CN101985620A Molecular marker SIsv1223 closely linked with millet herbicide-resistant gene |
03/16/2011 | CN101985612A Method for preparing mesenchymal stem cells in large scale by utilizing bioreactor |
03/16/2011 | CN101985611A Mammalian cell culture media which comprise supernatant from Cohn fractionation stages and use thereof |
03/16/2011 | CN101985476A Preparation, identification and application of antihuman NKp30 monoclonal antibody |
03/16/2011 | CN101985474A Monoclonal antibody TBCA6 resistant to mycobacterium tuberculosis CFP-10 and application |
03/16/2011 | CN101985473A Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application thereof |
03/16/2011 | CN101985472A Monoclonal antibody TBCD6 resistant to mycobacterium tuberculosis CFP-10 and application |
03/16/2011 | CN101985465A Soybean GmPHR1 gene and encoded protein and application thereof |
03/16/2011 | CN101985052A Skin substitute for automatically capturing endothelial progenitor cells and promoting vascularization and construction method thereof |
03/16/2011 | CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin |
03/15/2011 | US7906711 Soybean cultivar 6214260 |
03/15/2011 | US7906708 Slow-maturing, determinate peas |
03/15/2011 | US7906707 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
03/15/2011 | US7906638 Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains |
03/15/2011 | US7906637 Compositions and methods for inducing or inhibiting activities of selected human cells |
03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
03/15/2011 | US7906627 Chimeric human sweet-umami and umami-sweet taste receptors |
03/15/2011 | US7906490 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders |
03/15/2011 | US7906487 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
03/15/2011 | US7906484 Complex for transferring an anionic substance into a cell |
03/15/2011 | US7906335 Nutrient broth for propagation of nematophagus fungi |
03/15/2011 | US7906334 Method for reproducing conifers by somatic embryogenesis using lactose as a carbon source |
03/15/2011 | US7906333 Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same |
03/15/2011 | US7906332 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same |
03/15/2011 | US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP) |
03/15/2011 | US7906330 Two cell population comprising chondrocyte precursors and human embryonic stem cells |
03/15/2011 | US7906329 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
03/15/2011 | US7906328 Cell lines that express hetero oligomeric taste receptors |
03/15/2011 | US7906327 Dual expression vector system for antibody expression in bacterial and mammalian cells |
03/15/2011 | US7906323 Feedback controlled bioreactor for propagation of preferential cells |
03/15/2011 | US7906311 For production of viruses causing porcine reproductive and respiratory syndrome (PRRS) |
03/15/2011 | US7906300 Sodium/potassium ATPase regulation |
03/15/2011 | US7906298 Thermostable Photinus pyralis luciferase mutant |
03/15/2011 | US7906282 Synthetic nucleic acid molecule compositions and methods of preparation |
03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
03/15/2011 | US7906135 Medical device comprising polyhydroxyalkanoate having pyrogen removed |
03/15/2011 | US7906113 DNA viral vector comprising nucleotide seuences coding modified capsid protein for use in enhancement of heterologous gene transfer; improved exogenous gene expression |
03/15/2011 | US7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
03/15/2011 | US7906110 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
03/15/2011 | CA2494698C Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
03/15/2011 | CA2452005C Inhibition of apoptosis process and improvement of cell performance |
03/15/2011 | CA2429134C A method for generating genetically altered antigens |
03/15/2011 | CA2422230C Bio-reactor device |
03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
03/15/2011 | CA2392845C Maize mip synthase promoter |
03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
03/15/2011 | CA2163517C Surrogate tolerogenesis for the development of tolerance to xenografts |
03/15/2011 | CA2094511C Analogs of botanic seed |
03/10/2011 | WO2011029092A1 Klf family members regulate intrinsic axon regeneration ability |
03/10/2011 | WO2011029053A1 Human embryonic stem cells for high throughout drug screening |
03/10/2011 | WO2011029007A2 Human lymphoid tissue inducer (lti) cell compositions and methods of use |
03/10/2011 | WO2011028880A2 Methods for enhancing genome stability and telomere elongation in embryonic stem cells |
03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
03/10/2011 | WO2011028795A2 Methods for extraction and purification of gangliosides |
03/10/2011 | WO2011028690A1 Microbubble devices, methods and systems |
03/10/2011 | WO2011028681A2 Biologic soft tissue arthroplasty spacer and joint resurfacing of wrist and hand |
03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
03/10/2011 | WO2011028611A1 P2x7: inhibition of epithelial cancers and papillomas |
03/10/2011 | WO2011028579A2 Aligning cells on wrinkled surface |
03/10/2011 | WO2011028531A1 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
03/10/2011 | WO2011028524A1 Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same |
03/10/2011 | WO2011028390A1 Compositions and methods for potentiating interleukin-35 |